Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04627298 · ClinicalTrials.gov registry record · NA
Normalizing HPV Vaccination in Preteens With a Serious Video Game
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT04627298 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 55 participants.
The verdict
NCT04627298, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States and causes genital warts and cancers in both females and males. Vaccination against HPV is recommended for routine use in those aged 11-12 years old, yet is underutilized. The study's premise is that preteens are relevant decision makers who can be motivated to initiate and complete the HPV vaccine series (assuming parental consent and provider recommendation). This study evaluates a serious video game to engage preteens in the decision to pursue HPV vaccination. The hypothesis is that preteens who are assigned to the video game will be more likely to initiate and complete HPV vaccination than preteens who are not assigned to the video game.
Interventions
- BEHAVIORAL educational video game for preteens to support HPV vaccination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2015-07-09 |
| Est. Completion | 2019-04-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04627298
The ClinicalTrials.gov registry entry for NCT04627298 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which educational video game for preteens to support HPV vaccination is the first listed.
NCT04627298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04627298 about?
NCT04627298 is a clinical study titled "Normalizing HPV Vaccination in Preteens With a Serious Video Game". Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States and causes genital warts and cancers in both females and males. Vaccination against HPV is recommended for routine use in those aged 11-12 years old, yet is underutilized. The study's premise is that pr...
What is the current status of trial NCT04627298?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2015-07-09. Estimated completion is 2019-04-16.
What interventions are being tested in trial NCT04627298?
The interventions under investigation include: educational video game for preteens to support HPV vaccination (BEHAVIORAL).
Who is sponsoring clinical trial NCT04627298?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.